Sign in
4

Changes in Ownership

Citius Pharmaceuticals, Inc. Filed Acc 0001477932-16-011029

Options or other derivatives

  • Director acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kane William Director 2016-06-23 Grant or award · Options to Purchase Common Stock +200,000 $0.80 $160,000 200,000 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…